Diana Mckenzie is Director of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 2,436 shares of VRTX, which is worth approximately $1.22 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 1,168 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.44K
0% 3M change
69.76% 12M change
Total Value Held $1.22 Million

DIANA MCKENZIE Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
SELL
Sale (or disposition) back to the issuer
-
1,168 Reduced 32.41%
2,436 Common Stock
May 01 2024
BUY
Grant, award, or other acquisition
-
1,001 Added 21.74%
3,604 Common Stock
May 01 2023
SELL
Sale (or disposition) back to the issuer
-
1,449 Reduced 50.24%
1,435 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
1,168 Added 30.97%
2,603 Common Stock
May 01 2022
SELL
Sale (or disposition) back to the issuer
-
1,842 Reduced 56.21%
1,435 Common Stock
May 01 2022
BUY
Grant, award, or other acquisition
-
1,449 Added 33.44%
2,884 Common Stock
May 01 2021
BUY
Grant, award, or other acquisition
-
1,842 Added 35.98%
3,277 Common Stock

Also insider at

MET
METLIFE INC Financial Services
CHNG
Change Healthcare Inc.
AGL
agilon health, inc. Healthcare
DM

Diana Mckenzie

Director
Boston, MA

Track Institutional and Insider Activities on VRTX

Follow VERTEX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX